Sectors
Forest Labs to buy schizophrenia drug, cut costs
Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it plans to buy rights to a new schizophrenia treatment from Merck & Co and cut annual operating costs by $500 million in fiscal 2016.
Wipro of India enters acquisition deal of Opus Capital Markets for USD75 million
Wipro Ltd announced today in a statement that it is set to acquire Opus Capital Markets Consultants LLC, a US-based mortgage services provider in order to expand its offerings to its financial services clients.
Dow Chemical said it will exit from assets worth $5B
Dow Chemical revealed its plans today to divest its USD5 billion worth of assets, which was way more than the range chief executive Andrew Liveris initially declared in October.
Akamai buying Prolexic for $370 mln to boost DDoS protection
Akamai Technologies Inc said it will spend about $370 million to acquire Prolexic Technologies Inc, a pioneer in fighting distributed denial of service attacks, cyberthreats that cripple networks by overwhelming them with Internet traffic.